Company / Assets per Share
ELITE PHARMACEUTICALS INC /NV/ Assets per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Assets per Share
$0.09
FY2025
5-year range
$0.03 / $0.09
FY2021-FY2025
Trend
+9.4%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Assets per Share has increased for 5 consecutive years, from $0.03 in FY2020 to $0.09 in FY2025.
Based on SEC 10-K filings.
0.09 in FY2025 with a 5-year CAGR of +24.4%.
Improved from $0.04 to $0.09 over the past 2 years.
Assets per Share over time
Growth rates
- 3-Year CAGR
- +37.3%
- 5-Year CAGR
- +24.4%
- 10-Year CAGR
- -
Key checks
Key Insights
- ELITE PHARMACEUTICALS INC /NV/'s assets per share has grown for 5 consecutive years.
- In FY2025, assets per share increased 9.4% year-over-year.
- Lowest assets per share in the period was in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -0.19 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.09 | +9.4% |
| FY2024 | $0.08 | +104.0% |
| FY2023 | $0.04 | +16.1% |
| FY2022 | $0.03 | +11.8% |
| FY2021 | $0.03 | +3.0% |
| FY2020 | $0.03 | -0.5% |
| FY2019 | $0.03 | -8.6% |
| FY2018 | $0.03 | -31.0% |
| FY2017 | $0.05 | -3.9% |
| FY2016 | $0.05 | +8.5% |
As of FY2025 · SEC 10-K · Updated Jun 29, 2026